Latin America Lung Cancer Therapeutics Market by Treatment Type (Chemotherapy (Cisplatin, Taxol, Navelbine, Camptosar and Alimta), Radiotherapy (External Beam, Internal Beam and Systemic) and Other Drugs (Abraxane, Avastin, Crizotinib, Docetaxel and Gefitinib)) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Latin America Lung Cancer Therapeutics Market by Treatment Type (Chemotherapy (Cisplatin, Taxol, Navelbine, Camptosar and Alimta), Radiotherapy (External Beam, Internal Beam and Systemic) and Other Drugs (Abraxane, Avastin, Crizotinib, Docetaxel and Gefitinib)) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 897 | Pages: 138 | May 2017 | Region: Latin America


The Latin America Lung Cancer Therapeutics Market was worth $0.79 billion in 2016 and estimated to be growing at a CAGR of 7.29%, to reach $1.12 billion by 2021.

Lung Cancer is an uninhibited expansion of abnormal cells that initiates off in one or both lungs; for the maximum part in the cells that line the air units. The immediate cells don’t form into solid lung tissue but they expand rapidly and form tumours. As cancer become bigger and more in number, they decline the lung’s ability to deliver the bloodstream with oxygen.

Air pollution, amplified alcohol consumption, varying life style, smoking, unhealthy food, and no physical activity are the factors indirectly driving the market. Governments in the developing economies like Latin America region are providing awareness among the people about the cancer. High cost of the treatment and lack of consciousness among the people for initial recognition of cancer are detains for lung cancer therapeutics market.

The Latin America Lung Cancer Therapeutics Market is segmented on the basis of treatment type nto Chemotherapy, Radiotherapy and Other Drugs. Based on drug type, Lung Cancer Chemotherapy market is segmented into cisplatin, taxol, navelbine, camptosar and Alimta. Based on type, Lung Cancer Radiotherapy market is segregated into external beam, internal beam and systemic. On the basis of drug type, Other Lung Cancer Therapeutic Drugs market is segmented into abraxane, avastin, crizotinib, docetaxel and Gefitinib.  The top global brands that are commercially accessible in the market are Avastin, Alimta and taxol. Radiotherapy accounts for the largest segment in the lung cancer therapeutics market.

Based on geography the market is analysed under various regions namely, Brazil, Argentina and Mexico. Mexico is dominating the Latin America region lung cancer therapeutics market and estimated to continue its dominance over the forecast period, while Argentina is expected to witness high growth in coming years.

Companies are implementing various strategies to increase their product portfolio and rise its geographical presence. New product expansion, contracts and associations and procurements are some of the significant approaches adopted by the manufacturers in the lung cancer therapeutics market. The prominent players of this market include BoehringerIngelheim GmbH, Hoffman-La Roche, Pfizer Inc., GlaxoSmitKline, Eli Lilly and Company, Agennix AG, AstrazenecaPlc, and Sanofi-Aventis.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Treatment Type                                 

                                5.1.1 Chemotherapy                     

                                                5.1.1.1 Cisplatin

                                                5.1.1.2 Taxol      

                                                5.1.1.3 Navelbine            

                                                5.1.1.4 Camptosar          

                                                5.1.1.5 Alimta   

                                5.1.2 Radiotherapy                         

                                                5.1.2.1 External Beam   

                                                5.1.2.2 Internal Beam    

                                                5.1.2.3 Systemic              

                                5.1.3 Other Drugs                            

                                                5.1.3.1 Abraxane             

                                                5.1.3.2 Avastin 

                                                5.1.3.3 Crizotinib             

                                                5.1.3.4 Docetaxel            

                                                5.1.3.5 Gefitinib               

6. Geographical Analysis                                                              

                6.1 Introduction                                              

                6.2 Brazil                                             

                6.3 Mexico                                         

                6.4 Argentina                                    

                6.5 Rest of Latin America                                             

7. Pipeline Product Analysis                                                       

                7.1 Overview                                                    

                7.2 Pipeline Development Landscape                                                    

                7.3 Molecular Targets in the Pipeline                                                     

                7.4 Clinical Trials                                             

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target                       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                                  

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.                               

8. Strategic Analysis                                                       

                8.1 PESTLE analysis                                         

                                8.1.1 Political                     

                                8.1.2 Economic                 

                                8.1.3 Social                         

                                8.1.4 Technological                         

                                8.1.5 Legal                          

                                8.1.6 Environmental                      

                8.2 Porter’s Five analysis                                              

                                8.2.1 Bargaining Power of Suppliers                        

                                8.2.2 Bargaining Power of Consumers                    

                                8.2.3 Threat of New Entrants                     

                                8.2.4 Threat of Substitute Products and Services               

                                8.2.5 Competitive Rivalry within the Industry                      

9. Market Leaders' Analysis                                                        

                9.1 BoehringerIngelheim GmbH                               

                                9.1.1 Overview                

                                9.1.2 Product Analysis                   

                                9.1.3 Strategic Evaluation and Operations                            

                                9.1.4 Financial analysis                  

                                9.1.5 Legal issues                            

                                9.1.6 Recent Developments                       

                                9.1.7 SWOT analysis                       

                                9.1.8 Analyst View                          

                9.2 Hoffman-La Roche                                  

                9.3 Pfizer Inc.                                    

                9.4 GlaxoSmitKline                                         

                9.5 Eli Lilly and Company                                             

                9.6 AstrazenecaPlc                                         

                9.7 Sanofi-Aventis                                          

                9.8 Agennix AG                                

10. Competitive Landscape                                                         

                10.1 Market share analysis                                          

                10.2 Merger and Acquisition Analysis                                     

                10.3 Agreements, collaborations and Joint Ventures                                       

                10.4 New Product Launches                                       

11. Expert Opinions                                                        

                11.1 Market Outlook                                     

                11.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Latin America Lung Cancer Therapeutics Market By Region, From 2016-2021 (USD Billion)
  2. Latin America Lung Cancer Therapeutics Market By Treatment Type, From 2016-2021 (USD Billion)
  3. Latin America Chemotherapy Market By Region, From 2016-2021 (USD Billion)
  4. Latin America Radiotherapy Market By Region, From 2016-2021 (USD Billion)
  5. Latin America Other Lung Cancer Therapeutic Drugs Market By Region, From 2016-2021 (USD Billion)
  6. Brazil Lung Cancer Therapeutics Market By Treatment Type, From 2016-2021 (USD Billion)
  7. Argentina Lung Cancer Therapeutics Market By Treatment Type, From 2016-2021 (USD Billion)
  8. Mexico Lung Cancer Therapeutics Market By Treatment Type, From 2016-2021 (USD Billion)
  9. Latin America Lung Cancer Chemotherapy Market By Drug Type, From 2016-2021 (USD Billion)
  10. Latin America Cisplatin Market By Region, From 2016-2021 (USD Billion)
  11. Latin America Taxol Market By Region, From 2016-2021 (USD Billion)
  12. Latin America Navelbine Market By Region, From 2016-2021 (USD Billion)
  13. Latin America Camptosar Market By Region, From 2016-2021 (USD Billion)
  14. Latin America Alimta Market By Region, From 2016-2021 (USD Billion)
  15. Brazil Lung Cancer Chemotherapy Market By Drug Type, From 2016-2021 (USD Billion)
  16. Argentina Lung Cancer Chemotherapy Market By Drug Type, From 2016-2021 (USD Billion)
  17. Mexico Lung Cancer Chemotherapy Market By Drug Type, From 2016-2021 (USD Billion)
  18. Latin America Lung Cancer Radiotherapy Market By Type, From 2016-2021 (USD Billion)
  19. Latin America External Beam Market By Region, From 2016-2021 (USD Billion)
  20. Latin America Internal Beam Market By Region, From 2016-2021 (USD Billion)
  21. Latin America Systemic Market By Region, From 2016-2021 (USD Billion)
  22. Brazil Lung Cancer Radiotherapy Market By Type, From 2016-2021 (USD Billion)
  23. Argentina Lung Cancer Radiotherapy Market By Type, From 2016-2021 (USD Billion)
  24. Mexico Lung Cancer Radiotherapy Market By Type, From 2016-2021 (USD Billion)
  25. Latin America Other Lung Cancer Therapeutic Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  26. Latin America Abraxane Market By Region, From 2016-2021 (USD Billion)
  27. Latin America Avastin Market By Region, From 2016-2021 (USD Billion)
  28. Latin America Crizotinib Market By Region, From 2016-2021 (USD Billion)
  29. Latin America Docetaxel Market By Region, From 2016-2021 (USD Billion)
  30. Latin America Gefitinib Market By Region, From 2016-2021 (USD Billion)
  31. Brazil Other Lung Cancer Therapeutic Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  32. Argentina Other Lung Cancer Therapeutic Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  33. Mexico Other Lung Cancer Therapeutic Drugs Market By Drug Type, From 2016-2021 (USD Billion)
Middle-East & Africa Cardiovascular Therapeutic Drugs By Disease (Arteriosclerosis, Cardiac Arrhythmias, Myocardial Infarction, Acute Coronary Syndrome, Peripheral Artery Disease, Coronary Artery Disease, Hypertensi...
Middle East And Africa Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail...
Latin America Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmaci...
Asia Pacific Clostridium Botulinum Market By Product (botulinum Toxin Type A And Botulinum Toxin Type B), By End User (aesthetic And Therapeutics), By Distribution Channel (hospitals, Clinics And Retail Pharmacies) ...
Europe Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmacies) And...
North America Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmaci...
Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmacies) And By Reg...
The Dental Bone Graft Substitutes Market Is Predicted To Reach USD 664.3 Million With A CAGR Of 9.8% According To Market Data Forecast Report....
Middle East And Africa Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal D...
Latin America Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal Defect Reg...
Asia-Pacific Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal Defect Rege...
Europe Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal Defect Regenerati...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.